AC
ITOS

Almitas Capital’s iTeos Therapeutics ITOS Stock Holding History

Almitas Capital’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-487,204
Closed -$4.86M – 78
2025
Q2 		$4.86M Buy
487,204
+212,084
+77% +$1.71M 1.23% 19
2025
Q1 		$1.64M Hold
275,120
– – 0.55% 37
2024
Q4 		$2.11M Buy
+275,120
New +$2.36M 0.46% 34

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Almitas Capital's ITOS Position: Q3 2025 in Review

Almitas Capital sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 487,204 shares — an estimated $4.86M sold.

Almitas Capital first reported a position in ITOS in Q4 2024 and held it in 3 quarters. The position peaked at $4.86M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Almitas Capital reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Almitas Capital sold 487,204 iTeos Therapeutics shares in Q3 2025, an estimated $4.86M.
  • Almitas Capital first reported a position in iTeos Therapeutics in Q4 2024 and held it in 3 quarters.
  • Almitas Capital's iTeos Therapeutics position peaked at $4.86M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Almitas Capital's 13F filing for Q3 2025, filed 14 Nov 2025.